Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage



Principal Investigator
Michael Diringer, MD & Raj Dhar, MD

PI Address
Michael Diringer, MD & Raj Dhar, MD
Washington University Medical Center
St Louis, Missouri, United States, 63110

Contact Address
Abbie Bradely, RN
Phone: 314-747-8882 Email: BradleyA@nsurg.wustl.edu

Sponsor



Trial Phase:Phase II
Study Size Planned:48
Centers Planned:1
Max Time from onset:1 Hours
Min Age:18
Follow-up Duration:2 Weeks
ISRCTN#NCT00968227
Status:
This study is currently recruiting participants.

Purpose:
To determine if giving blood transfusions to anemic patients with subarachnoid hemorrhage will reduce their chances of having a stroke from vasospasm.

Interventions:
Red blood cell transfusion
Red blood cells - cells that carry oxygen to and from tissues and organs

Location(s):
St. Louis, Missouri

Year Started: 2007

Design:
Interventional, Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study.

Inclusion Criteria
Aneurysmal SAH confirmed by angiography; Hemoglobin < 12.5 gm/dl; One of the following: a) considered at increased risk for vasospasm by care team or b) angiographic vasospasm;
delayed ischemic deficit; able to be studied within 2 weeks after subarachnoid hemorrhage.

Exclusion Criteria
Active Coronary Artery Disease; severe congestive heart failure; Jehovah's witness; unable to obtain appropriately matched blood; other contraindications for transfusion; pregnancy.

Patient Involvement:
Patients will be randomized to receive a transfusion of 1 unit of packed red blood cells over 1 hour.

Primary Outcome:
Regional cerebral oxygen delivery.

Secondary Outcome:
Regional cerebral oxygen extraction fraction in regions with low baseline cerebral oxygen delivery and regions with angiographic vasospasm.

Comments:
Scientific Name: Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage

Source of Information:
ClinicalTrials.gov

Web Links and Publications:
Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage.
Stroke 2009 Sep;40(9):3039-44

Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage
ClinicalTrials.gov

This information last updated on: 11/6/2009

Reviewed on: 11/06/2009.

UID: 1047

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009